Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis

Plant Biotechnology Journal

Volumn 11, Issue 1, 2013, Pages 66-76

  Wakasa, Yuhya ^a   Takagi, Hidenori ^a   Hirose, Sakiko ^b   Yang, Lijun ^a   Saeki, Mayumi ^c   Nishimura, Tomoe ^c   Kaminuma, Osamu ^c   Hiroi, Takachika ^c   Takaiwa, Fumio ^a  

^a NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF CROP SCIENCE   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Allergy; Cry j 1; Cry j 2; Immunotherapy; Oral tolerance; Pollinosis; Transgenic rice

Indexed keywords

CRY J I PROTEIN, CRYPTOMERIA JAPONICA; PLANT ANTIGEN; PLANTIBODY; VEGETABLE PROTEIN;

ANIMAL; ARTICLE; CHEMISTRY; GENETICS; HAY FEVER; IMMUNOLOGY; IMMUNOTHERAPY; JAPANESE CEDAR; METHODOLOGY; MOLECULAR FARMING; MOUSE; ORAL DRUG ADMINISTRATION; PLANT SEED; POLLEN; RICE; TRANSGENIC PLANT;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, PLANT; CRYPTOMERIA; IMMUNOTHERAPY; MICE; MOLECULAR FARMING; ORYZA SATIVA; PLANT PROTEINS; PLANTIBODIES; PLANTS, GENETICALLY MODIFIED; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEEDS;

CRYPTOMERIA JAPONICA; MUS; RHODOCOCCUS RHODOCHROUS;

EID: 84871687702     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/pbi.12007     Document Type: Article

References (53)

1. Akdis, M. and Akdis, C.A. (2007) Mechanisms of allergen-specific immunotherapy. J. Allergy Clin. Immunol. 119, 780-789.
2. Ali, F.R. and Larche, M. (2005) Peptide-based immunotherapy: a novel strategy for allergic disease. Expert Rev. Vaccines, 4, 881-889.
3. Bohle, B., Kinaciyan, T., Gerstmayr, M., Radakovics, A., Jaohn-Schmid, B. and Ebner, C. (2007) Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J. Allergy Clin. Immunol. 120, 707-713.
4. Bousquet, J. and Demoly, P. (2006) Specific immunotherapy-an optimistic future. Allergy, 61, 1155-1158.
5. Burks, A.W., Laubach, S. and Jones, S.M. (2008) Oral tolerance, food allergy and immunotherapy: Implications for future treatment. J. Allergy Clin. Immunol. 121, 1344-1350.
6. Canonica, G.W. and Passalacqua, G. (2003) Noninjection routes for immunotherapy. J. Allergy Clin. Immunol. 111, 437-448.
7. Cromwell, O., Hafner, D. and Nandy, A. (2011) Recombinant allergens for specific immunotherapy. J. Allergy Clin. Immunol. 127, 865-872.
8. Faria, A.M. and Weiner, H.L. (2005) Oral tolerance. Immunol. Rev. 206, 232-259.
9. Focke, M., Swoboda, I., Marth, K. and Valenta, R. (2010) Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity. Clin. Exp. Allergy, 40, 385-397.
10. Frew, A.J. (2003) Immunotherapy of allergic disease. J. Allergy Clin. Immunol. 111, S712-S719.
11. + leukocytes, is a potential therapeutic biomarker for sublingual immunotherapy: a preliminary report. Int. Arch. Allergy Immunol. 153, 378-387.
12. Gardner, L.M., Spyroglou, L., O'Hehir, R.E. and Rolland, J.M. (2004) Increased allergen concentration enhances IFN-γ production by allergic donor T cell expressing a peripheral tissue trafficking phenotype. Allergy, 59, 1308-1317.
13. Hashimoto, M., Nigi, H., Sakaguchi, M., Inouye, S., Imaoka, K., Miyazawa, H., Taniguchi, Y., Kurimoto, M., Yasueda, H. and Ogawa, T. (1995) Sensitivity to two major allergens (Cry j 1 and Cry j 2) in patients with Japanese cedar (Cryptomeria japonica) pollinosis. Clin. Exp. Allergy, 25, 848-852.
14. Hirahara, K., Saito, S., Serizawa, N., Sasaki, R., Sakaguchi, M., Inouye, S., Taniguchi, Y., Kaminogawa, S. and Shiraishi, A. (1998) Oral administration of a dominant T-cell determinant peptide inhibits allergen-specific Th1 and Th2 cell responses in Cry j 2-primed mice. J. Allergy Clin. Immunol. 102, 961-967.
15. Iida, S., Kusaba, M. and Nishio, T. (1997) Mutants lacking glutelin subunits in rice: mapping and combination of mutated glutelin. Theor. Appl. Genet. 94, 177-183.
16. Immonen, A., Farci, S., Taivainen, A., Partanen, J., Pouvelle-Moratille, S., Narvanen, A., Kinnunen, T., Saarelainen, S., Rytkonen-Nissinen, M., Maillere, B. and Virtanen, T. (2005) T cell epitope-containing peptides of the major dog allergen Can f 1 as candidates for allergen immunotherapy. J. Immunol. 15, 3614-3620.
17. Juntel, M., Akdis, M., Blaser, K. and Akdis, C.A. (2006) Mechanisms of allergen specific immunotherapy - T cell tolerance and more. Allergy, 61, 796-807.
18. Kaminuma, O., Suzuki, K. and Mori, A. (2010) Effect of sublingual immunotherapy on antigen-induced bronchial and nasal inflammation in mice. Int. Arch. Allergy Immunol. 152, 75-78.
19. Larche, M. (2007) Peptide immunotherapy for allergic diseases. Allergy, 62, 325-331.
20. Larche, M., Akdis, C.A. and Valenta, R. (2006) Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 6, 761-771.
21. Linhart, B. and Valenta, R. (2005) Molecular design of allergy vaccines. Curr. Opin. Immumnol. 17, 645-655.
22. Mayer, L. and Shao, L. (2004) Therapeutic potential off oral tolerance. Nat. Rev. Immunol. 4, 407-419.
23. Murasugi, T., Nakagami, Y., Yoshitomi, T., Hirahara, K., Yamashita, M., Taniguchi, Y., Sakaguchi, M. and Ito, K. (2005) Oral administration of a T cell epitope inhibits symptoms and reactions of allergic rhinitis in Japanese cedar pollen allergen-sensitized mice. Eur. J. Pharmacol. 510, 143-148.
24. Naal, R.M.Z.G., Tabb, J., Holowka, D. and Baird, B. (2004) In situ measurement of degranulation as a biosensor based on RBL-2H3 mast cells. Biosens. Bioelectron. 20, 791-796.
25. Niederberger, V. and Valenta, R. (2006) Molecular approaches for new vaccines against allergy. Expert Rev. Vaccines, 5, 103-110.
26. Niederberger, V., Horak, F., Vrtala, S., Spitzauer, S., Krauth, M.T., Valent, P., Reisinger, L., Pelzmann, M., Hayek, B., Kronqvist, M., Gafvelin, G., Gronlund, H., Purohit, A., Suck, R., Fiebig, H., Cromwll, O., Pauli, G., van Hage-Hamsten, M. and Valenta, R. (2004) Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc. Natl. Acad. Sci. USA, 101, 14677-14682.
27. Okamoto, Y., Horiguchi, S., Yamamoto, H., Yonekura, S. and Hanazawa, T. (2009) Present situation of cedar pollinosis in Japan and its immune responses. Allergol. Int. 58, 155-162.
28. Okubo, K. and Gotoh, M. (2009) Sublingual immunotherapy for Japanese cedar pollinosis. Allergol. Int. 58, 149-154.
29. Oono, Y., Wakasa, Y., Hirose, S., Yang, L., Sakuta, C. and Takaiwa, F. (2010) Analysis of ER stress in developing rice endosperm accumulating β-amyloid peptide. Plant Biotechnol. J. 8, 691-718.
30. Ozdemir, C., Akdis, M. and Akdis, C.A. (2009) T regulatory cells and their counterparts: masters of immune regulation. Clin. Exp. Allergy, 39, 626-639.
31. + cells in the nasal mucosa. J. Allergy Clin. Immunol. 121, 1467-1472.
32. Sakaguchi, M., Inouye, S., Taniai ., M., Ando, S., Usui, M. and Matuhasi, T. (1990) Identification of the second major allergen of Japanese cedar pollen. Allergy, 45, 309-312.
33. Sakaguchi, M., Hashimoto, M., Nigi, H., Yasueda, H., Takahashi, Y., Watanabe, M., Nagoya, T., Taniguchi, Y., Kurimoto, M. and Inouye, S. (1997) Epitope specificity of IgE antibodies to a major allergen (Cry j 1) of Japanese cedar (Cryptomeria japonica) pollen in sera of humans and monkeys with pollinosis. Immunology, 91, 161-166.
34. Suzuki, K., Kaminuma, O., Yang, L., Takai, T., Mori, A., Umezu-Goto, M., Ohtomo, T., Ohmachi, Y., Noda, Y., Hirose, S., Okumura, K., Ogawa, H., Takada, K., Hirasawa, M., Hiroi, T. and Takaiwa, F. (2011) Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression. Plant Biotech. J. 9, 982-990.
35. Suzuki, K., Yang, L. and Takaiwa, F. (2012) Transgenic rice accumulating modified cedar pollen allergen Cry j 2 derivatives. J. Biosci. Bioeng. 113, 249-251.
36. Tada, Y., Utsumi, S. and tand Takaiwa, F. (2003) Foreign gene products can be enhanced by introduction into low storage protein mutants. Plant Biotechnol. J. 1, 411-422.
37. Takagi, H., Hiroi, T., Yang, L., Tada, Y., Yuki, Y., Takamura, K., Ishimitsu, R., Kawauchi, H., Kiyono, H. and Takaiwa, F. (2005a) A rice-based edible vaccine expressing multiple epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Proc. Natl. Acad. Sci. USA, 102, 17525-17530.
38. Takagi, H., Saito, S., Yang, L., Nagasaka, S., Nishizawa, N. and Takaiwa, F. (2005b) Oral immunotherapy against a pollen allergy using a seed-based peptide vaccine. Plant Biotechnol. J. 3, 521-533.
39. Takagi, H., Hiroi, T., Hirose, S., Yang, L. and Takaiwa, F. (2010) Rice seed ER-derived protein body as an efficient delivery vehicle for oral tolerogenic peptides. Peptides, 31, 1421-1425.
40. Takaiwa, F. (2007) Transgenic rice seed as a nutriceutical delivery system. CAB Rev. Perspect. Agri. Vet. Sci. Nutr. Nat. Resour. 2, 041.
41. Takaiwa, F. (2011) Seed-based oral vaccines as allergen-specific immunotherapies. Hum. Vaccin. 7, 357-366.
42. Takaiwa, F., Hirose, S., Takagi, H., Yang, L. and Wakasa, Y. (2009) Deposition of a recombinant peptide in ER-derived protein bodies by retention with cysteine-rich prolamins in transgenic rice seed. Planta, 229, 1147-1158.
43. Till, S.J., Francis, J.N., Nouri-Aria, K. and Durham, S.R. (2004) Mechanisms of immunotherapy. J. Allergy Clin. Immunol. 113, 1025-1034.
44. Tsunematsu, M., Yamaji, T., Kozutsumi, D., Murakami, R., Kimura, S. and Kino, K. (2007) Effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, on an experimental allergic rhinitis model in B10.S mice. Allergol. Int. 56, 465-472.
45. Valenta, R. and Kraft, D. (2002) From allergen structure to new forms of allergen-specific immunotherapy. Curr. Opin. Immunol. 14, 718-727.
46. Valenta, R. and Niederberger, V. (2007) Recombinant allergens for immunotherapy. J. Allergy Clin. Immunol. 119, 826-830.
47. Valenta, R., Ferreira, F., Focke-Tejkl, M., Linhart, B., Niederberger, V., Swoboda, I. and Vrtala, S. (2010) From allergen genes to allergy vaccines. Annu. Rev. Immunol. 28, 211-241.
48. Verma, D., Moghimi, B., LoDuca, P., Singh, H., Hoffman, B., Herzog, R. and Daniell, H. (2010) Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice. Proc. Natl. Acad. Sci. USA, 107, 7101-7106.
49. Wakasa, Y., Yasuda, H. and Takaiwa, F. (2006) High accumulation of bioactive peptide in transgenic rice seeds by expression of introduced multiple genes. Plant Biotechnol. J. 4, 499-510.
50. Wakasa, Y., Ozawa, K. and Takaiwa, F. (2007) Agrobacterium-mediated transformation of a low glutelin mutant of 'Koshihikari' rice variety using the mutated-acetolactate synthase gene derived from rice genome as a selectable marker. Plant Cell Rep. 26, 1567-1573.
51. Wakasa, Y., Yang, L. and Takaiwa, F. (2009) Production of bioactive peptide. In: transgenic rice seed. In Modification of Seed Composition to Promote Health and Nutrition (Krishunan, H., ed.), pp. 101-120. Agronomy Monograph Series 51, Madison, WI, USA: ASA and SSSA.
52. Yang, L., Suzuki, K., Hirose, S., Wakasa, Y. and Takaiwa, F. (2007) Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen (Cry j 1) structurally disrupted for oral immunotherapy. Plant Biotechnol. J. 5, 815-826.
53. Yasueda, H., Yui, Y., Shimizu, T. and Shida, T. (1983) Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen. J. Allergy Clin. Immunol. 71, 77-86.